Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Puma Biotechnology 

10940 Wilshire Blvd, Suite 600

Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


 Company News
Puma Biotechnology (PBYI) Initiates Phase II Trial Of PB272 In Early Stage HER2-Positive Breast Cancer 3/10/2015 8:24:12 AM
Puma Biotechnology (PBYI) Reports Fourth Quarter And Full Year 2014 Financial Results 3/3/2015 11:56:16 AM
Puma Biotechnology (PBYI) To Present At Cowen and Company Health Care Conference 2/25/2015 10:51:16 AM
Puma Biotechnology (PBYI) To Participate In Fireside Chat At RBC Capital Markets’ Global Healthcare Conference 2/19/2015 12:15:16 PM
Puma Biotechnology (PBYI) To Present At Leerink Global Healthcare Conference 2/6/2015 11:54:54 AM
Puma Biotechnology (PBYI) Closes $218 Million Public Offering Of Common Stock 1/28/2015 11:31:26 AM
Puma Biotechnology (PBYI) Announces Underwriters’ Full Exercise Of Option To Purchase Additional Shares 1/23/2015 10:25:21 AM
Puma Biotechnology (PBYI) Announces Proposed Public Offering 1/21/2015 12:51:29 PM
Puma Biotechnology (PBYI) To Present At J.P. Morgan Healthcare Conference 1/6/2015 11:27:00 AM
Puma Biotechnology (PBYI) Announces Positive Interim PB272 (Neratinib) Phase 2 Data At 2014 CTRC-American Association for Cancer Research San Antonio Breast Cancer Symposium 12/12/2014 8:12:35 AM